Why the U.S. recommended suspending Johnson & Johnson’s vaccine, and what it means for Canada – CBC

Canada is expecting 10 million doses of the vaccine starting this month

Apr 13, 2021

On Tuesday, the U.S. recommended putting on hold the use of the single-dose Johnson & Johnson COVID-19 vaccine.

The U.S. Centers for Disease Control and Prevention and the Food and Drug Administration (FDA) said in a joint statement they are investigating blood clots in six women in the days after vaccination, in combination with reduced platelet counts.

Canada has approved the vaccine but hasn’t yet received any doses. Here’s what we know about what led the U.S. to make this decision, and what it could mean for Canada.

What do we know about the cases?

In the U.S., the only country using the vaccine, all six cases were among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination.

Read more: https://www.cbc.ca/news/health/johnson-johnson-vaccine-1.5986097